- CEO
- Amandip Jagpal
- Full Time Employees
- 1
- Sector
- Industrials
- Industry
- Conglomerates
- Address
- 2383 King George Boulevard Surrey BC Canada V4A5A4
- IPO Date
- Feb 4, 2014
- Business
- Crown Baus Capital Corp. (OTC: CBCA) operates as an acquisition-based conglomerate focused on high-tech industries and financial services; it currently conducts no significant operations but pursues vertical integration of industrial, commercial, and retail profit centers through partnerships and start-ups in segments including high-tech incubation, drug development, entertainment and media, education, and financial services. The company offers acquisition and integration services targeting synergistic opportunities across these sectors, with historical involvement in cannabis-related ventures such as the 2018 acquisition of Cannabia, the world's first alcoholic cannabis beer, which operates as a subsidiary alongside partnerships like Cannabis Science Inc. for distribution and drug development initiatives. Founded in 2011 and headquartered at Suite 204, 2383 King George Blvd, Surrey, British Columbia V4A 5A4, Canada, Crown Baus Capital maintains global ambitions through consultants aiding target identification and capital procurement, trading on OTCPK with approximately 161 million shares outstanding and two executive employees. Recent strategic shifts include a going concern emphasis in its April 2023-filed 10-K for fiscal years ended April 30, 2021, and 2020, highlighting a $47 million accumulated deficit, minimal cash reserves, and reliance on future equity or debt financing up to $2 million for operations amid no revenue generation; prior deals like the canceled dupetit acquisition and 2014-2018 negotiations underscore ongoing efforts to secure high-tech and blockchain opportunities without material updates since 2021.